TREPANOSTIKA TP RECOMBINANT - Registration ANVISA nº 10158120502, Reference 285034 - Lots D37FA and D37FB, Reference 285035 - Lots D37FA and D37FB - Validity: 06/2007, 07/2007 and 08/2007 의 안전성 경고

Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.

The Company informs that after risk assessment, it reiterates that there is no sanitary impact, since in case of occurrence of the problem, the race is given with invalid. He also states that there was no question from the customers who purchased the product. For further clarification, please contact your local representative or the customer service department - Biomérieux 0800264848. The Company, through a file sent to UTVIG dated March 16, 2007, informs the closing of the collection.